Media & Resources

Scientific Publications

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

IAVI Report

From the editor — a new IAVI Report

April 27, 2022

After 25 years of IAVI Report, we’re making a few changes. In 2020, life changed for many across the globe. As SARS-CoV-2 began its deadly march through humankind, countries entered lockdown, offices and schools closed, and many of us who weren’t on the so-called front lines of the pandemic were largely sheltered within our homes.…

IAVI Report

The future of mRNA-based HIV vaccines is about more than speed

April 27, 2022

Right now in vaccine research, mRNA has the momentum. For HIV, there are currently several formulations of experimental vaccines in early-stage human clinical trials. Apart from some overlap in strategy, they have one main thing in common — they rely on mRNA. This trend reflects the intense overall interest in mRNA-based vaccine development, given its…

IAVI Report

Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis

April 27, 2022

A conversation with Jon Cohen about what made writing about this pandemic different and what stories are still to be told.

Scientific Publications

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Scientific Publications

Evaluating the effectiveness of enhanced family planning education on knowledge and use of family planning in fishing communities of Lake Victoria in Uganda: a randomized controlled trial

Press Releases

IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies

April 7, 2022

Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis.

Scientific Publications

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

1…35 363738 39…218 of 218

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

From the editor — a new IAVI Report

The future of mRNA-based HIV vaccines is about more than speed

Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Evaluating the effectiveness of enhanced family planning education on knowledge and use of family planning in fishing communities of Lake Victoria in Uganda: a randomized controlled trial

IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

From the editor — a new IAVI Report

The future of mRNA-based HIV vaccines is about more than speed

Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Evaluating the effectiveness of enhanced family planning education on knowledge and use of family planning in fishing communities of Lake Victoria in Uganda: a randomized controlled trial

IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

Subscription Type